At the last check on Friday, China SXT Pharmaceuticals Inc.’s (NASDAQ:SXTC) stock was down -$0.01, moving down -6.12 percent to $0.20. The average number of shares traded per day over the past five days has been 537,645 shares. 3 times new highs have been achieved over the past 5 days, with a $0.0070 gain in that time frame. In the last twenty days, the average volume was 332,666, while in the previous 50 days, it was 429,544.
Since last month, SXTC stock retreated -8.69%. Shares of the company fell to $0.1718 on 07/27/23, the lowest level in the past month. A 52-week high of $2.18 was reached on 01/17/23 after having rallying from a 52-week low of $0.17. Since the beginning of this year, SXTC’s stock price has dropped by -63.66% or -$0.3420, and marked a new high 6 times. However, the stock has declined by -90.97% since its 52-week high.
Valuation Metrics
The stock’s beta is 0.77. Besides these, the trailing price-to-sales (P/S) ratio of 0.79, the price-to-book (PB) ratio of 0.03.
Financial Health
In the recent quarter, China SXT Pharmaceuticals Inc.’s quick ratio stood at 1.60, while its current ratio was 1.70, showing that the company is able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 48.10% percent. Based on annual data, SXTC earned $0.43 million in gross profit and brought in $1.97 million in revenue.
The liabilities of China SXT Pharmaceuticals Inc. were 7.29 million at the end of its most recent quarter, and its total debt was $8.96 million.
Technical Picture
This quick technical analysis looks at China SXT Pharmaceuticals Inc.’s (SXTC) price momentum. With a historical volatility rate of 77.57%, the RSI 9-day stood at 50.03% on 03 August.
With respect to its five-day moving average, the current China SXT Pharmaceuticals Inc. price is up by +3.63% percent or $0.0070. At present, SXTC shares trade -7.02% below its 20-day simple moving average and -33.33% percent below its 100-day simple moving average. However, the stock is currently trading approximately -17.66% below its SMA50 and -70.15% below its SMA200.
Stochastic coefficient K was 62.28% and Stochastic coefficient D was 55.15%, while ATR was 0.0202. Given the Stochastic reading of 44.34% for the 14-day period, the RSI (14) reading has been calculated as 47.89%.
Analyst Ratings
China SXT Pharmaceuticals Inc. (SXTC) has been rated – by analysts. According to 0 brokerage firms, SXTC is a sell, and 0 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate China SXT Pharmaceuticals Inc. stock as buy, with 0 recommending it as overweight.
